A Dual Role of Cyclin E in Cell Proliferation and Apotosis May Provide a Target for Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|4|1|65-75

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.4, Iss.1, 2004-02, pp. : 65-75

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CDK9/cyclin T1: a host cell target for antiretroviral therapy

By Klebl Bert M   Choidas Axel  

Future Virology, Vol. 1, Iss. 3, 2006-05 ,pp. : 317-330

Future Medicine

Access to resources Recommend Favorite

Cyclin-Dependent Kinase-2 as a Target for Cancer Therapy: Progress in the Development of CDK2 Inhibitors as Anti-Cancer Agents

By  

Current Medicinal Chemistry, Vol. 22, Iss. 2, 2014-12 ,pp. : 237-263

Bentham Science Publishers

Access to resources Recommend Favorite

Conflicting evidence for the role of JNK as a target in breast cancer cell proliferation: Comparisons between pharmacological inhibition and selective shRNA knockdown approaches

By  

Pharmacology Research & Perspectives, Vol. 6, Iss. 1, 2018-02 ,pp. : n/a-n/a

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeting the Cancer Initiating Cell: The Ultimate Target for Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 18, Iss. 13, 2012-05 ,pp. : 1784-1795

Bentham Science Publishers

Access to resources Recommend Favorite

E2F1-Mediated Apoptosis as a Target of Cancer Therapy

By  

Current Molecular Pharmacology, Vol. 2, Iss. 2, 2009-06 ,pp. : 149-160

Bentham Science Publishers

Access to resources Recommend Favorite